2017
DOI: 10.3390/v9120392
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of HIV-1 Near Full-Length Proviral Genome Quasispecies from Patients with Undetectable Viral Load Undergoing First-Line HAART Therapy

Abstract: Increased access to highly active antiretroviral therapy (HAART) by human immunodeficiency virus postive (HIV+) individuals has become a reality worldwide. In Brazil, HAART currently reaches over half of HIV-infected subjects. In the context of a remarkable HIV-1 genetic variability, highly related variants, called quasispecies, are generated. HIV quasispecies generated during infection can influence virus persistence and pathogenicity, representing a challenge to treatment. However, the clinical relevance of … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
21
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 20 publications
(23 citation statements)
references
References 109 publications
(138 reference statements)
1
21
0
Order By: Relevance
“…The two patients are at a higher risk of therapy failure. Characterization of HIV-1 proviral DNA would be helpful in the monitoring of HIV drug resistance variants clinical impact of regimens and treatment success [3]. Characterization of the proviral genome was indicated to have significance in monitoring HIV minority drug resistant variants in Brazil [3].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The two patients are at a higher risk of therapy failure. Characterization of HIV-1 proviral DNA would be helpful in the monitoring of HIV drug resistance variants clinical impact of regimens and treatment success [3]. Characterization of the proviral genome was indicated to have significance in monitoring HIV minority drug resistant variants in Brazil [3].…”
Section: Discussionmentioning
confidence: 99%
“…Characterization of HIV-1 proviral DNA would be helpful in the monitoring of HIV drug resistance variants clinical impact of regimens and treatment success [3]. Characterization of the proviral genome was indicated to have significance in monitoring HIV minority drug resistant variants in Brazil [3]. Although our samples are limited to nine numbers, genotyping test may be giving valuable information which would be helpful for HIV drug resistant variants in the region of the northern part of India.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…We used the method already published [29,30] analysis [31]. The study was carried out using only the Pol RT part region of the sequences obtained.…”
Section: Ngs Of Hiv Proviral Dnamentioning
confidence: 99%
“…Recently, Ji et al [ 10 ] recommended best practices for processing HIV NGS data, which include reference-based assembly using Bowtie2 [ 11 ] as the short read aligner and HXB2 (NCBI accession: K03455; [ 12 ]) as the reference sequence for constructing a consensus sequence. Many studies implement reference-based assembly [ 10 , 13 , 14 ] with tools such as CLC Main Workbench (Qiagen, Hilden, Germany) [ 15 , 16 , 17 , 18 ], Geneious ( ) [ 19 , 20 , 21 , 22 , 23 , 24 ], HyDRA [ 25 , 26 , 27 , 28 ], SmartGene (Switzerland) [ 21 , 29 , 30 ], PAseq [ 31 , 32 ] and Amplicon Variant Analyzer (AVA; pyrosequencing-based platform) [ 21 , 33 , 34 , 35 , 36 , 37 ]. Other studies complete de novo assembly with tools such as Geneious [ 38 ], CLC Main Workbench (Qiagen) [ 16 , 39 , 40 ], and Iterative Virus Assembler (IVA) [ 22 , 41 , 42 , 43 , 44 , 45 , 46 , 47 ].…”
Section: Introductionmentioning
confidence: 99%